Elisa Cerqui

2.3k total citations
19 papers, 285 citations indexed

About

Elisa Cerqui is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Elisa Cerqui has authored 19 papers receiving a total of 285 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 7 papers in Genetics and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Elisa Cerqui's work include Acute Myeloid Leukemia Research (12 papers), Chronic Myeloid Leukemia Treatments (7 papers) and Acute Lymphoblastic Leukemia research (5 papers). Elisa Cerqui is often cited by papers focused on Acute Myeloid Leukemia Research (12 papers), Chronic Myeloid Leukemia Treatments (7 papers) and Acute Lymphoblastic Leukemia research (5 papers). Elisa Cerqui collaborates with scholars based in Italy and Germany. Elisa Cerqui's co-authors include Erika Borlenghi, Giuseppe Rossi, Chiara Pagani, Francesca Schieppati, Chiara Cattaneo, Angela Passi, Simona Sica, Francesco Lo‐Coco, Giuseppina Ruggeri and Alessandra Tucci and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Elisa Cerqui

18 papers receiving 284 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Elisa Cerqui	203	91	83	59	50	19	285
Giuseppina Loglisci	191 0.9×	50 0.5×	130 1.6×	59 1.0×	56 1.1×	23	278
Federica Lessi	139 0.7×	89 1.0×	94 1.1×	137 2.3×	65 1.3×	30	377
Kazuya Ishiwata	269 1.3×	36 0.4×	67 0.8×	105 1.8×	42 0.8×	54	373
M.L. Martino	145 0.7×	84 0.9×	65 0.8×	64 1.1×	88 1.8×	16	280
José Falantes	198 1.0×	88 1.0×	44 0.5×	63 1.1×	73 1.5×	29	291
Stefano D’Ardìa	210 1.0×	73 0.8×	86 1.0×	89 1.5×	41 0.8×	26	302
Nadira Duraković	132 0.7×	40 0.4×	66 0.8×	37 0.6×	42 0.8×	34	261
Radwan Massoud	245 1.2×	56 0.6×	52 0.6×	158 2.7×	37 0.7×	51	397
Sigrid Machherndl‐Spandl	159 0.8×	87 1.0×	63 0.8×	38 0.6×	14 0.3×	36	248
Yuewen Fu	147 0.7×	29 0.3×	52 0.6×	68 1.2×	50 1.0×	40	265

Countries citing papers authored by Elisa Cerqui

Since Specialization

Citations

This map shows the geographic impact of Elisa Cerqui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Cerqui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Cerqui more than expected).

Fields of papers citing papers by Elisa Cerqui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisa Cerqui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Cerqui. The network helps show where Elisa Cerqui may publish in the future.

Co-authorship network of co-authors of Elisa Cerqui

This figure shows the co-authorship network connecting the top 25 collaborators of Elisa Cerqui. A scholar is included among the top collaborators of Elisa Cerqui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisa Cerqui. Elisa Cerqui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Borlenghi, Erika, Erika Borlenghi, Irene Terrenato, et al.. (2024). Impact of Infectious Complications Should be Considered When Choosing Chemotherapy for Elderly Acute Myeloid Leukemia Fit Patients: Results of a Large Monocentric Retrospective Study. Blood. 144(Supplement 1). 5946–5946.

Borlenghi, Erika, Chiara Cattaneo, Diego Bertoli, et al.. (2022). Prognostic Relevance of NPM1 and FLT3 Mutations in Acute Myeloid Leukaemia, Longterm Follow-Up—A Single Center Experience. Cancers. 14(19). 4716–4716. 4 indexed citations

Borlenghi, Erika, Chiara Cattaneo, Elisa Cerqui, et al.. (2020). Postremission therapy with repeated courses of high‐dose cytarabine, idarubicin, and limited autologous stem cell support achieves a very good long‐term outcome in European leukemia net favorable and intermediate‐risk acute myeloid leukemia. Hematological Oncology. 38(5). 754–762. 8 indexed citations

Borlenghi, Erika, Chiara Pagani, Patrizia Zappasodi, et al.. (2020). Validation of the “fitness criteria” for the treatment of older patients with acute myeloid leukemia: A multicenter study on a series of 699 patients by the Network Rete Ematologica Lombarda (REL). Journal of Geriatric Oncology. 12(4). 550–556. 13 indexed citations

Falconi, Giulia, Emiliano Fabiani, Marianna Criscuolo, et al.. (2019). Transcription factors implicated in late megakaryopoiesis as markers of outcome after azacitidine and allogeneic stem cell transplantation in myelodysplastic syndrome. Leukemia Research. 84. 106191–106191. 4 indexed citations

D’Adda, Mariella, Mirko Farina, Francesca Schieppati, et al.. (2019). The e13a2 BCR‐ABL transcript negatively affects sustained deep molecular response and the achievement of treatment‐free remission in patients with chronic myeloid leukemia who receive tyrosine kinase inhibitors. Cancer. 125(10). 1674–1682. 46 indexed citations

Cattaneo, Chiara, Michele Malagola, Chiara Pagani, et al.. (2019). Invasive pulmonary aspergillosis in acute leukemia: a still frequent condition with a negative impact on the overall treatment outcome. Leukemia & lymphoma. 60(12). 3044–3050. 12 indexed citations

Farina, Mirko, Mariella D’Adda, Nicola Polverelli, et al.. (2019). PF688 JAK2 ALLELIC RATIO IMPACTS ON VASCULAR EVENT IN MYELOFIBROSIS BY INCREASING THE RISK OF THROMBOSIS. A SINGLE CENTER EXPERIENCE ON 150 PATIENTS. HemaSphere. 3(S1). 298–298. 1 indexed citations

Bassan, Renato, Sabina Chiaretti, Ernesta Audisio, et al.. (2019). Phase II trial with sequential clofarabine and cyclophosphamide for refractory and relapsed philadelphia-negative adult acute lymphoblastic leukemia. Results of the GIMEMA LAL 1610 protocol. Leukemia & lymphoma. 60(14). 3482–3492. 1 indexed citations

10.

Zappasodi, Patrizia, Laura Marbello, Erika Borlenghi, et al.. (2018). Molecular remission at the end of treatment is a necessary goal for a good outcome in ELN favorable-risk acute myeloid leukemia: a real-life analysis on 201 patients by the Rete Ematologica Lombarda network. Annals of Hematology. 97(11). 2107–2115. 2 indexed citations

11.

Falconi, Giulia, Emiliano Fabiani, Alfonso Piciocchi, et al.. (2018). Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes. Leukemia. 33(3). 785–790. 24 indexed citations

12.

D’Adda, Mariella, Mirko Farina, Francesca Schieppati, et al.. (2017). An e13a2 Type of BCR-ABL Transcript Has a Significant Adverse Impact on the Achievement of a Sustained Deep Molecular Response and on the Maintenance of a Treatment Free Remission after Stopping Tyrosine Kinase Inhibitors. Blood. 130. 1589–1589. 3 indexed citations

13.

Voso, Maria Teresa, Giuseppe Leone, Alfonso Piciocchi, et al.. (2017). Feasibility of allogeneic stem-cell transplantation after azacitidine bridge in higher-risk myelodysplastic syndromes and low blast count acute myeloid leukemia: results of the BMT-AZA prospective study. Annals of Oncology. 28(7). 1547–1553. 39 indexed citations

14.

Cerqui, Elisa, Francesca Schieppati, Erika Borlenghi, et al.. (2015). Lenalidomide in patients with red blood cell transfusion-dependent myelodysplastic syndrome and del(5q): a single-centre “real-world” experience. Leukemia & lymphoma. 56(11). 3129–3134. 1 indexed citations

15.

Malagola, Michele, Cristina Skert, Erika Borlenghi, et al.. (2015). Postremission sequential monitoring of minimal residual disease by WT1 Q‐PCR and multiparametric flow cytometry assessment predicts relapse and may help to address risk‐adapted therapy in acute myeloid leukemia patients. Cancer Medicine. 5(2). 265–274. 27 indexed citations

16.

Efficace, Fabio, Franco Mandelli, Giuseppe Avvisati, et al.. (2014). Randomized Phase III Trial of Retinoic Acid and Arsenic Trioxide Versus Retinoic Acid and Chemotherapy in Patients With Acute Promyelocytic Leukemia: Health-Related Quality-of-Life Outcomes. Journal of Clinical Oncology. 32(30). 3406–3412. 57 indexed citations

17.

Cattaneo, Chiara, Mario Tumbarello, Cristina Skert, et al.. (2013). Relapsing bloodstream infections during treatment of acute leukemia. Annals of Hematology. 93(5). 785–790. 17 indexed citations

18.

Cattaneo, Chiara, Erika Borlenghi, Francesca Schieppati, et al.. (2013). Impact Of Posaconazole Prophylaxis On Invasive Fungal Infection During Acute Myeloid Leukemia Induction Therapy: Correlation With Posaconazole Serum Levels. Blood. 122(21). 3484–3484. 2 indexed citations

19.

Cattaneo, Chiara, Suzanne M. de la Monte, Alessandra Algarotti, et al.. (2011). A randomized comparison of caspofungin versus antifungal prophylaxis according to investigator policy in acute leukaemia patients undergoing induction chemotherapy (PROFIL-C study). Journal of Antimicrobial Chemotherapy. 66(9). 2140–2145. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact